Prognostic Role of the Ratio between Cyclooxygenase-2 in Tumor and Stroma Compartments in Cervical Cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Analysis of Binary Data

2008 • 2,760 citations

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

2000 • 2,505 citations

Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells

1998 • 2,282 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors

1994 • 1,107 citations

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

2002 • 786 citations

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer

2001 • 510 citations

Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis

2000 • 474 citations

COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease

2000 • 305 citations

Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.

2000 • 305 citations

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

2003 • 229 citations

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

2001 • 189 citations

Using Cyclooxygenase-2 Inhibitors as Molecular Platforms to Develop a New Class of Apoptosis-Inducing Agents

2002 • 165 citations

Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients

2002 • 159 citations

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

2002 • 157 citations

The Second Generation of COX-2 Inhibitors

2003 • 149 citations

Cyclooxygenase‐2 expression in endometrial carcinoma

2002 • 115 citations

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

2002 • 114 citations

Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

2002 • 113 citations

Chemoradiotherapy: Emerging treatment improvement strategies

2002 • 110 citations

Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma

2001 • 92 citations

Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.

1994 • 84 citations

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.

2002 • 72 citations

Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.

2003 • 68 citations

Phase I–II Trial of Preoperative Chemoradiation in Locally Advanced Cervical Carcinoma

2000 • 64 citations

Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.

2002 • 52 citations

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

2002 • 52 citations

Elevated COX-2 Expression in Cervical Carcinoma

2001 • 45 citations

High cyclooxygenase-2 expression in cervical adenocarcinomas

2003 • 45 citations

Impaired monocyte function in cancer patients: restoration with a cyclooxygenase‐2 inhibitor

2002 • 43 citations

Modified type IV‐V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with Stage III cervical carcinoma: Feasibility, technique, and clinical results

1996 • 38 citations

Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with Stage III cervical carcinoma: Feasibility, technique, and clinical results

1996 • 38 citations

Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery

2002 • 25 citations

Selective inhibition of cyclooxygenase-2 inhibits growth and induces apoptosis in human esophageal adenocarcinoma cells

2000 • 22 citations

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a cyclooxygenase 2-specific inhibitor, JTE-522, and conventional anticancer agents

2001 • 11 citations